Protagonist: Oral peptide win for Protagonist/J&J, Beam's base editor POC, and more: Clinical Report

MAR 11, 2025 | 5:13 PM PDT | BIOCENTURY | PRODUCT DEVELOPMENTORAL PEPTIDE WIN FOR PROTAGONIST/J&J, BEAM'S BASE EDITOR POC, AND MORE: CLINICAL REPORTBY Protagonist data led to week's biggest share price gain, while Arvinas saw biggest loss: in BioCentury's latest Clinical Reporthttps://www.biocentury.com/article/655316/oral-peptide-win-for-protagonist-j-j-beam-s-base-editor-poc-and-more-clinical-report© 2025 BioCentury Inc. All Rights Reserved